Background. Autoimmune thyroiditis (AT) is one of the most common endocrine disorders affecting a significant percent of the population, especially women. It may have serious and long-lasting consequences. The etiology of AT is multifactorial and it arises from an interplas between environmental and genetic factors. Tendencies in AT prevalence and incidence are unclear. In Poland there are no national registers covering the data on AT prevalence.
Autoimmune thyroiditis (AT) is a common disorder of the thyroid gland. It is usually diagnosed when thyroid autoantibodies (TPOAbs/TGAbs) are detected in patients with hypothyroidism or goiter. It is assumed that thyroid autoimmunity may affect 2% of males and more than 10% of females, while thyroid dysfunction due to AT occurs in 2% of the population. 1 The etiology of AT is complex and not fully explained. 2 The disease arises as a result of an interplay between genetic and environmental factors. Among genes that may contribute to AT one can count: HLA-DR3, HLA-DRβ1-Arg74, HLA-DR pocket-sequence variant and non-MHC genes e.g. CD40, CTLA-4, PTPN22, thyreoglobulin and TSH receptor genes. The environmental influences comprise: smoking, stress, iodine intake, medications, bacterial and viral infections, irradiation, pollutants and pregnancy. It is emphasized that epigenetic effects may play an important role in thyroid autoimmunity. 3, 4 Common experience suggests that the incidence of AT is increasing. Although some studies point to such a trend in the incidence and prevalence of AT, real patterns of the disorder are not easy to trace and compare. [5] [6] [7] [8] The aim of the present study was to evaluate whether there was any change in the prevalence of AT in a sample of Polish population consulted in LUXMED centers in the period 2006-2013.
Material and methods
In order to assess the prevalence of AT a search of LUXMED database was performed. LUXMED (part of BUPA) is the leading private healthcare provider in Poland offering services through a chain of 140 company's medical centers. The company's services are offered primarily to people paying a monthly fee (corporate clients), but single, paid consultations are provided as well. It is estimated that the company's database comprised around 230,000 patients (mainly corporate) in 2006 and 1,200,000 (including 800,000 corporate) in 2013. The annual number of consultations in the company's clinics exceeds 3,000,000 including more than 155,000 endocrinology consultations. It can be assumed that LUXMED corporate patients are professionally active (the majority between 20-50, practically all under 65), work in the private sector (or are self-employed), earn more than average, their jobs do not involve much physical activity and are not significant exposed to chemicals/toxins/radiation. Most of them reside in cities/towns rather than in villages.
The main search term used in the present investigation was E06.3 (autoimmune thyroiditis, AT). The diagnosis of AT required the presence of autoantibodies (TPOAbs/ TGAbs) in association with goiter/thyroid atrophy/typical ultrasound findings or hypothyroidism. It was made solely during endocrinology consultations. Each entry was counted once for a specific patient. The acquired data was compared with the number of endocrinology consultations in the given year and the number of patients in whom the diagnosis of hypothyroidism (E03 with exclusion of E03.2, E03. 5 
Results
In the studied period a highly significant trend in the prevalence of AT was observed (c 2 = 0,85, df = 1, p < 0.00013) and there was a highly significant association (c 2 = 908,17, df = 7, p < 0.0001) between the number of patients diagnosed with AT and specific years ( Fig. 1 , Table 1 ).
Between 2006 and 2007 a steep decrease in AT frequency from 10.4% to 6.5% was noted. In the next two years the frequencies were respectively above 5 and 3%. In 2007 a transient increase of AT frequency to 5.8% was followed by a decrease to the level below 5% in the last years. The analysis of correlation confirmed the presence of linear (r = -0.9816, p < 0.00001) and rank correlation (r = 1.0000, p < 0.00001) between the number of AT patients and the consecutive years.
A highly significant trend (c 2 = 476.64, df = 1, p < 0.00001) and association (c 2 = 2657.79, df = 7, p < 0.0001) was also found for the diagnosis of hypothyroidism (E03). In 2006 the prevalence of hypothyroid patients was very high, close to 18%, however it dropped to 7.6% in 2007. In the following years the number of patients diagnosed with hypothyroidism at endocrinology consultations fluctuated between 7.3 and 12.9% and settled at 7.7% in 2013. The analysis of correlation coefficients showed linear (r = -0.9433, p = 0.0004) and rank (r = 0.9524, p = 0.0003) associations between the number of patients with hypothyroidism and the consecutive years.
Endocrinologists diagnosed AT most often in subjects aged 30-39. The second group in which AT prevalence was high was the group between 20 and 29 years of age. The diagnosis was made significantly more often in women than in men in 2 age groups: 20-29 (p = 0.0005) and 30-39 (p = 0.0186). In other age groups there were no considerable differences of AT prevalence between sexes (Fig. 2) .
A comparison of data from 4 distinguished areas of the country: north (Olsztyn, Trójmiasto, Szczecin), south (Katowice, Tychy, Opole, Kraków, Dębica, Zabierzów), middle (Warszawa, Łódź, Aleksandrów Łódzki, Bydgoszcz) and west (Wrocław, Poznań, Gorzów Wielkopolski) revealed geographical differences of the prevalence of AT in all age groups apart from patients under 19 and aged 30-39 (Fig. 3) .
The number of AT in the age group 20-29 was lowest in the north and highest in the south of Poland (p = 0.0007). To the contrary, the prevalence of AT was lowest in the south of Poland in patients aged 40-49, 50-59 and over 60 ( Table 2 , Fig. 4 ).
There was a statistically significant difference of the prevalence of AT depending on the area of the country (c 2 = 104.93, df = 3, p < 0.0001). The diagnosis was made most frequently in the west (0.0544) and least frequently -in the south of Poland (0.043). 
Discussion
Prevalence of the thyroid autoantibody positivity is relatively high worldwide. It is well-known that in iodinesufficient areas there is a higher rate of AT prevalence than in iodine-deficient ones (9) . Iodine intake is probably one of the most important factors that affects thyroid autoimmunity and the incidence of AT. 10 In a random sample of general, euthyroid population living in Holland (n = 2703) the prevalence of the TPOAbs positive cases was 8.4%. 11 In Denmark among 4649 randomly selected subjects between 18 and 65 years of age 13.1% were TPOAbs positive and 18.1% had increased concentrations of either TPO or TG autoantybodies. 12 In the United States, TPOAbs were positive in 11.3% and TGAbs in 10.4% in a population sample of 13,344 subjects. In Japan among 1818 adults 31.4% of women and 17.7% of men were positive for TgAbs or TPOAbs. 13 In another study from the same country presence of TPOAbs or TGAbs was reported in 12.8% of the studied cases.
14 A very similar number (12.4% TPOAb positivity) was noted also by Australian authors. 15 In India TPOAbs were detected in more than 13% subjects from a group of 4409 adults and 22% from a sample of 5376 adults. 16, 17 Generally, TPOAbs are present in 12-26% of euthyroid subjects, more often in women. 18 These observations are in line with the data on the prevalence of hypothyroidism. In Europe the prevalence of undiagnosed and diagnosed hypothyroidism is estimated to be between 3.05 and 4.94%. 8 In the United States 4.6% of the population has hypothyroidism. 19 In Japan overt or subclinical hypothyroidism is noted in 6.5% of the population, while in India subclinical hypothyroidism is diagnosed in 15.9% of men and 21.4% of women (overall prevalence 19.3%). 13, 17 In Poland information on thyroid function/thyroid autoimmunity was gathered, e.g. in 4190/1594 subjects over 55 years of age in the framework of the PolSenior study. In this cross-sectional investigation 17.4% of subjects were TPOAb positive and 7.9% could be classified as hypothyroid. The prevalence of TPOAb seropositivity was higher in females than in males (27 vs 15%) (20) .
As expected, also in our sample more women than men were diagnosed with AT (and hypothyroidism, data not presented). Such results were concordant with observations of hypothyroidism from Poland and other countries. 8, 19, 20 It is more difficult to say whether there is a rising trend in AT occurrence over the years. Such an impression emerges from an analysis of studies conducted in the United Kingdom, Slovenia and Denmark. 7 In Australia thyroid autoantybodies were detected in 9.8 of women and 2.8% of men in 1975 and in 1981 these ratios changed into respectively 17 and 6.8%. 7, 21 A hypothesis of an increasing incidence of thyroid autoimmunity is also supported by results of an Italian investigation performed in a rural community of 1411/1148 subjects. In this study a clear rise in the number of thyroid autoantybodies positive cases was noted between 1995 and 2010. TPOAbs positivity rose from 12.6 to 19.5% (p < 0.001) and AT from 3.5 to 14.5% (p < 0.0001). 10 In concordance with the above findings are observations of Danish cohorts from 1997-1998 and 2004-2005 . The positivity for TPOAbs changed from 14.3 to 23.8% and for TGAbs from 13.7 to 19.9% after introducing mandatory iodization of salt. 22 Also in Poland, obligatory iodine prophylaxis (which started in 1997) was associated with a clear increase in the percent of TPOAbs positive individuals from 3.8 to 11.8%. Over the period of 10 years (1989-1999) the prevalence of hypothyroidism ratios in the city of Kraków increased insignificantly in women and men from respectively 1.4 to 2.1% and from 0 to 0.3%. 23 Our data does not confirm increasing trends in AT occurrence. They correspond to some extent with the results of a comparison of two population surveys (33,917/49,180 individuals) performed in 1995-1997 and 2006-2008 in Norway. The Scandinavian authors noted a decrease in the prevalence of overt hypothyroidism in women from 0.75 to 0.12% (84%) and in men from 0.21 to 0.12% (43%). The prevalence of subclinical hypothyroidism changed from 3.0 to 1.1% (64%) in women and from 2.1 to 1.0% (54%) in men. Conversely, the prevalence of treated hypothyroidism among women increased by 60% from 5.0 to 8.0% in men by 100% from 1.0 to 2.0%. It must be admitted that the prevalence of all forms of hypothyroidism did not change remarkably, as it was found in 9% of women and 3% of men. 24 The strength of the present study is a relatively high number of observations made in clinics from all over the country. Unlike other medical conditions (e.g. neoplasms, contagious diseases) thyroid pathology is not covered by any public database of a national scale. According to the report of the Central Statistical Office (http://www.stat. gov.pl/gus/5840_12706_ENG_HTML.htm), the number of endocrinology consultations in outpatient clinics in Poland (public sector) was around 4,000,000 in 2012. The consultations covered by our study (127 567 in 2012) would constitute 3.2% of the whole number of endocrinology consultations.
The data was acquired from an ethnically homogenous population from an area with sufficient iodine intake dating back to 1997. 25 Although the criteria of AT (or hypothyroidism) could not be imposed, it should be stressed that the diagnoses were made only by endocrinologists.
A limitation of the investigation is the fact that the majority of the subjects from the sample live in urban environments, are employed and under 65. The lifestyle parameters may not reflect the situation of the general population. One may assume that the economical status of the consulted patients is higher than average. The latter may be associated with e.g. diet/eating habits. The presented results could not be controlled for age, smoking status, pregnancy, concomitant ailments or received medications either. 
Conclusions
It seems there is a downward trend in the prevalence of autoimmune thyroiditis (AT) in privately insured patients in Poland over the years. Whether this is true for the whole population needs to be confirmed.
Young female patients aged 20-39 suffer from AT most often. There are relatively more cases in the southern areas of the country.
